AIRG News

This week’s three IPOs raised a combined $263 million. Continuing a streak of outperformance from larger IPOs, contract research organization Medpace led with a 21% gain, while Protagonist Therapeutics was the latest biotech IPO to break issue. Currently in the middle of its annual summer hiatus, the IPO market saw no new filings or launches this week. Since the IPO...read more

Airgain, which supplies embedded antennas for Wi-Fi routers and other electronic devices, raised $12 million by offering 1.5 million shares at $8, below the range of $9 to $10. Airgain plans to list on the Nasdaq under the symbol AIRG. Northland Securities and Wunderlich Securities acted as lead managers on the deal....read more

Four companies are set to raise a combined $270 million in the week ahead. Most notable deal Medpace, a contract research organization focused on biotechs, is joined by two potential customers: Protagonist Therapeutics and Motif Bio. Thanks to insider support, biotechs are the most active segment of the 2016 IPO market, with 20 offerings year-to-date (36% of total), but their...read more

Airgain, which supplies embedded antennas for Wi-Fi routers and other electronic device, announced terms for its IPO on Friday. The San Diego, CA-based company plans to raise $14 million by offering 1.5 million shares at a price range of $9 to $10. At the midpoint of the proposed range, Airgain would command a fully diluted market value of $78 million. Airgain was founded...read more